Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren’s Syndrome

https://clinicaltrials.gov/ct2/show/NCT03905525?type=Intr&cond=Sjogren%27s+Syndrome&lupd_s=10%2F14%2F2019&lupd_d=14&sort=nwst STUDY TITLE: Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren’s Syndrome DESCRIPTION: Condition:   Sjögren SyndromeInterventions:   Drug: CFZ533;   Other: PlaceboSponsor:   Novartis PharmaceuticalsRecruiting CLINICALTRIALS.GOV IDENTIFIER: NCT03905525 FIRST POSTED: Fri, 05 Apr 2019 12:00:00 EDT LAST UPDATE POSTED: 10/28/19 11:40AM STUDY LINK / URL: https://clinicaltrials.gov/ct2/show/NCT03905525?type=Intr&cond=Sjogren%27s+Syndrome&lupd_s=10%2F14%2F2019&lupd_d=14&sort=nwst

Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren’s Syndrome (TWINSS)

https://www.clinicaltrials.gov/ct2/show/NCT03905525 Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren’s Syndrome (TWINSS)